<b id="lnedg"><form id="lnedg"></form></b>
<cite id="lnedg"><noscript id="lnedg"><samp id="lnedg"></samp></noscript></cite><rt id="lnedg"><optgroup id="lnedg"><acronym id="lnedg"></acronym></optgroup></rt>
<b id="lnedg"></b>

    <font id="lnedg"></font>

    <rt id="lnedg"></rt>
  1. <tt id="lnedg"></tt>
    <rt id="lnedg"></rt>

    <tt id="lnedg"></tt><u id="lnedg"><tbody id="lnedg"><label id="lnedg"></label></tbody></u>

        <cite id="lnedg"></cite>
        1. Products

           Pravastatin Sodium
           Mycophenolic Acid

          Contact: Mr. Kang / Ms. Lin
          TEL:  0086-763-3865280
          FAX:  0086-763-3366526
          ADD:  Renmin One Road 
           Qingyuan Guangdong
          P.C.:  511515






          Common Name:Mevastatin/Compactin

          QUALITY STANDARD:In-house specifications (content: more than 95.0%)

          CAS Registry Number:73573-88-3

          Molecular Formula:C23H34O5

          Molecular Mass:390.51

          Structural Formula

          Chemical  Name: 2-Methyl-butanoic acid [1S-[1-alpha(R*),7-beta,8-beta(2S*,4S*), 8a-beta]]-1,2,3,7, 8,8a-hexahydro-7-methyl-8-[2-(tetrahydro-4-hydroxy- 6-oxo-2H-pyran-2-yl)ethyl]-1 -naphthalenyl ester                                          

          Therapeutic Category: Starting material used in the production of API Pravastatin Sodium

          Mechanism of action: Compaction, also known as Mevastatin, is an inhibitor of HMG-CoA  reductase. Compactin functions by inhibiting the enzyme HMG-CoA reductase, an  enxyme involved in the biosynthenic pathway of cholesterol. Although Compactin  is active in lowering cholesterol levels in humans, a derivative of Compactin,  named Pravastatin, was found to be more efficacious in this function. Thus, generally  Compactin is used as a starting material of Pravastatin.
          Download the contract



          粵公網安備 44180202000306號  網站備案:粵ICP備16104045號 互聯網藥品信息服務資格證書(粵)—非經營性—2021—0443